[ Price : $8.95]
Federal Register notice: FDA announces the renewal of its Science Board for an additional two years.[ Price : $8.95]
Troutman Pepper attorneys explain the potential benefits in FDAs new Emerging Drug Safety Technology Program.[ Price : $8.95]
FDA plans to ask its Vaccines and Related Biological Products Advisory Committee to discuss potential safety concerns related to p...[ Price : $8.95]
The National Institutes of Health ends a trial of an mpox antiviral drug that failed to produce an efficacy signal.[ Price : $8.95]
Johnson & Johnson reports data from its Phase 3 CARTITUDE-4 study that show Carvykti significantly increased minimal residual dise...[ Price : $8.95]
Two men are convicted of securities fraud in a case involving misrepresented submissions to FDA for a drug purportedly intended to...[ Price : $8.95]
FDA warns Chinas Guangzhou Four Es Scientific Co. about CGMP violations in its production of finished drugs.